Cite
MLA Citation
Lucia Nogova et al.. “Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.” Cancer medicine, vol. 9, 2020, pp. 4991–5007. http://access.bl.uk/ark:/81055/vdc_100105153317.0x00000b